A plan to make drugs in orbit is going commercial

2026-05-13 · Source: MIT Technology Review · Field: Science & Research — Engineering & Applied Sciences, Space Science & Astronomy, Health & Medical Research · Depth: Fundamental Awareness, medium

Summary

Varda Space Industries, a California-based startup, has partnered with pharmaceutical company United Therapeutics to explore in-orbit drug manufacturing, marking a significant step towards commercial space-based production. The collaboration aims to leverage microgravity conditions to create novel crystal forms (polymorphs) of United Therapeutics' drugs, potentially leading to improved stability or other valuable properties not achievable on Earth. Varda utilizes SpaceX's frequent and affordable launches to send small satellites with attached capsules into orbit, where drug crystallization experiments are conducted. These capsules then re-enter Earth's atmosphere at high speeds, landing with parachutes, and have also been used for military research related to hypersonic missile technology. The high value-to-weight ratio of pharmaceuticals, exemplified by drugs like Ozempic, makes them a viable candidate for space manufacturing despite the high cost of orbital launches.

Key takeaway

For pharmaceutical executives considering drug reformulation or patent extension strategies, exploring microgravity crystallization with companies like Varda could uncover novel polymorphs with superior characteristics. Your R&D investment in orbital experiments might yield new drug versions with enhanced stability or efficacy, potentially extending market exclusivity and improving patient outcomes, despite the initial experimental nature of the approach.

Key insights

Microgravity offers a unique environment for drug crystallization, potentially yielding novel polymorphs with enhanced properties.

Principles

• Microgravity alters chemical mixture properties.
• High-value products justify space manufacturing costs.

Method

Launch drug samples into orbit via reusable rockets, allow crystallization in microgravity, then return capsules to Earth for analysis of novel crystal forms.

In practice

• Reformulate existing drugs for improved properties.
• Explore new drug delivery methods (e.g., injections).

Topics

• Varda Space Industries
• United Therapeutics
• In-Orbit Manufacturing
• Microgravity Crystallization
• Drug Polymorphs

Best for: Executive, Entrepreneur, Investor

Related on AIssential

• SpaceX launches secretive Starfall reentry demo mission — SpaceX's Starfall capsule aims to democratize microgravity access for manufacturing and research, despite initial mission secrecy.
• The Download: making drugs in orbit and NASA’s nuclear-powered spacecraft — Space-based manufacturing and advanced propulsion are transforming aerospace, while AI and data privacy issues dominate tech discourse.
• There aren’t enough rockets for space data centers — Cowboy Space raised $275M to build them — Orbital data centers face launch capacity constraints, prompting a vertically integrated approach to rocket development.
• NASA selects Eric Schmidt’s rocket company for a 2028 mission to Mars — NASA's Aeolus mission utilizes private sector rocket technology to advance Martian atmospheric science and future human exploration.
• The Exploration Company completes drop test of Nyx capsule — The Exploration Company is advancing its Nyx cargo spacecraft and engine development through rigorous testing and significant funding efforts.
• BREAKING: Tamil Nadu Bets ₹100 Crore on Space - IN-SPACe Facility to Power Private Space Economy — Tamil Nadu is investing ₹100 Crore with IN-SPACe to establish a space manufacturing hub near its spaceport.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by MIT Technology Review.